Barry Ritz, Vice President of Scientific and Regulatory Affairs for Atrium Innovations Accepts 2016 NBJ Business Award for Achievement in Science and Innovation.
Leading industry publication praises company’s dedication to furthering the science behind supplements.
Montreal (Quebec), June 21, 2016 — Atrium Innovations Inc., a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based, nutritional supplements, has been named the recipient of the prestigious 2016 NBJ Business Award for Achievement in Science and Innovation. The Nutrition Business Journal formally presented the award last week as part of the 2016 NBJ Summit in Dana Point, California, praising the company’s history of leading innovation and long-standing commitment to being on the forefront of furthering the science and education behind nutritional supplements.
“At Atrium Innovations, we are committed to investing in research, and leveraging that research to develop safe, effective products for healthcare practitioners and health-conscious consumers. We are devoted to doing things the right way — that begins with our research efforts, and carries through to our ingredient sourcing, strict manufacturing requirements and quality assurance process,” said Barry Ritz, Vice President of Scientific and Regulatory Affairs for Atrium Innovations. “It is truly an honor to be recognized for this commitment to science and industry thought leadership.”
Atrium Innovations’ unique applied clinical research program not only focuses on the research and innovation of Atrium’s own products, but also serves to elevate the status of nutrition science through cutting-edge research and innovative partnerships. Recently, Atrium brand Pure Encapsulations launched a $1 million, multi-year partnership with the Cleveland Clinic Center for Functional Medicine supporting initiatives in clinical research, education, medical curriculum development, and policy change. Atrium has also engaged in a multi-year, multi-million dollar partnership with the Institute of Nutrition and Functional Foods at Laval University that focuses on investigating the role of nutrition on cardiometabolic health. This partnership has not only yielded key findings in the field of nutrition science but has also led to the development of several new formulas backed by clinical findings. In addition to these efforts, Atrium actively supports top academic partners worldwide on an ongoing basis through the provision of study products, matched placebos and technical expertise. Atrium’s continuous advancement of nutrition science, both through applied clinical research and investigator-initiated programs, has resulted in the publication of over 26 original research papers in peer-reviewed scientific journals to date, with another 20 studies still in progress.
For more information about the NBJ award, read the 2016 awards issue.
For more information about Atrium Innovations’ commitment to research, please visit atrium-innovations.com/research.
About Atrium Innovations
Atrium Innovations Inc. is a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based, natural health products that are distributed in more than 35 countries. The company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education. Atrium has over 1,300 employees and operates seven manufacturing facilities, all of which comply with Current Good Manufacturing Practices. The family of Atrium Innovations brands includes Pure Encapsulations, Garden of Life, Wobenzym, Genestra Brands, Douglas Laboratories and Klean Athlete.
Additional information is available at atrium-innovations.com.